IDEAYA Biosciences to Participate in Investor Conferences in February 2022
Post Views: 347 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in an investor conference in February 2022. Guggenheim Oncology DayWednesday, February 9, 2022 at 3:30pm ET Fireside chat with Yujiro Hata, Chief Executive Officer, hosted by Charles…